Biolex Therapeutics
Research Triangle Park, NC
CEO: Jan Turek
Biolex is a clinical-stage biopharmaceutical company that manufactures proteins for pharmaceutical partners and is developing its own proteins using its proprietary LEX system. The initial drug developed and manufactured by Biolex, Locteron, is in Phase 2b clinical testing for the treatment of chronic hepatitis C.
